Bulman Page et al.
7
1
)
1
.42 (m, 2 H), 6.18 (br s, 1 H), 4.93 (br s, 1 H), 2.51-2.42 (m,
H), 1.89 (t, J ) 4.2 Hz, 1 H), 1.76-1.71 (m, 1 H), 1.67 (dd, J
[2.2.1]h ep t -2-ylid en ]a m in o}et h a n a m id e (11b ). 4-Chlo-
robenzyl cyanide (178 µL, 228 mg, 1.50 mmol) was treated with
1 according to procedure B and the reaction mixture was
stirred for 3 h. Upon purification, (2R)-2-(4-chlorophenyl)-2-
{[(1R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yliden]amino}-
ethanamide (11a , 165 mg, 34%) was first eluted followed by
(2S)-2-(4-chlorophenyl)-2-{[(1R,4S)-1,7,7-trimethylbicyclo[2.2.1]-
hept-2-yliden]amino}ethanamide (11b, 218 mg, 46%).
12.1, 3.1 Hz, 1 H), 1.56 (d, J ) 17.5 Hz, 1 H), 1.28-1.18 (m,
H), 1.07 (s, 3 H), 0.92 (s, 3 H), 0.92-0.88 (m, 1 H), 0.77 (s, 3
1
3
H); C NMR (100.6 MHz, CDCl ) δ 186.1 (Cquat), 176.0 (Cquat),
3
1
1
6
36.9 (Cquat), 133.3 (Cquat), 133.0 (Cquat), 128.3 (CH), 128.1 (CH),
27.7 (CH), 126.4 (CH), 126.1 (CH), 126.0 (CH), 125.2 (CH),
8.1 (CH), 54.5 (Cquat), 47.2 (Cquat), 43.9 (CH), 36.0 (CH ), 31.8
), 27.2 (CH ), 19.7 (CH ), 19.0 (CH ), 11.4 (CH ); MS m/z
34 (M ), 305, 291, 290, 265, 222, 199, 185, 172, 155, 141, 127,
2
2
5
(CH
2
2
3
3
3
11a : pale yellow oil; [R]
-113° (c 1.02, CHCl ); IR ν
D
3
max
+
-1
1
3
1
3
(neat)/cm 3429, 3200, 1694; H NMR (250 MHz, CDCl ) δ
3
7.46 (br s, 1 H), 7.38-7.32 (m, 2 H), 7.29-7.25 (m, 2 H), 6.13
(br s, 1 H), 4.73 (s, 1 H), 2.47-2.35 (m, 1 H), 1.92 (t, J ) 4.3
Hz, 1 H), 1.87-1.61 (m, 2 H), 1.52 (d, J ) 17.2 Hz, 1 H), 1.29-
1.14 (m, 1 H), 1.04 (s, 3 H), 0.93 (s, 3 H), 0.96-0.84 (m, 1 H),
+
08, 95, 81, 69, 55, 43; HRMS calcd for C22
H
26
N
2
O (M )
34.20451, found 334.20367.
2
5
9
b: colorless solid, mp 145-150 °C; [R]
3
D
+115° (c 1.01,
-
1
1
CHCl
MHz, CDCl
); IR νmax (neat)/cm 3429, 1694, 1651; H NMR (250
) δ 7.86-7.75 (m, 4 H), 7.62 (br s, 1 H), 7.56 (dd,
0.75 (s, 3 H); 13C NMR (62.9 MHz, CDCl
) δ 185.3 (Cquat), 174.9
(Cquat), 137.1 (Cquat), 133.2 (Cquat), 128.5 (2 CH), 128.4 (2 CH),
67.1 (CH), 54.5 (Cquat), 47.0 (Cquat), 43.7 (CH), 35.9 (CH ), 31.6
(CH ), 27.0 (CH ), 19.4 (CH ), 18.8 (CH ), 11.1 (CH ).
11b: colorless needles, mp 145-146 °C; [R] +146° (c 1.04,
3
3
J ) 8.7, 1.7 Hz, 1 H), 7.48-7.40 (m, 2 H), 5.68 (br s, 1 H), 4.96
(
(
(
1
1
br s, 1 H), 2.04-1.65 (m, 5 H), 1.44-1.34 (m, 1 H), 1.29-1.19
2
m, 1 H), 1.09 (s, 3 H), 0.89 (s, 3 H), 0.47 (s, 3 H); 13C NMR
2
2
3
3
3
2
5
100.6 MHz, CDCl
3
) δ 186.1 (Cquat), 175.9 (Cquat), 136.5 (Cquat),
33.4 (Cquat), 133.0 (Cquat), 128.3 (CH), 128.1 (CH), 127.7 (CH),
26.3 (CH), 126.1 (CH), 126.0 (CH), 125.1 (CH), 68.7 (CH), 54.5
quat), 47.9 (Cquat), 43.9 (CH), 36.0 (CH ), 32.1 (CH ), 27.4
CH ), 19.4 (CH ), 19.1 (CH ), 11.6 (CH ); MS m/z 335 (MH ),
34 (M ), 291, 274, 261, 246, 234, 222, 206, 193, 185, 168, 156,
41, 128, 109, 95, 81, 69, 55, 41; HRMS calcd for C22
D
-
1
1
CHCl ); IR ν
3
max
(neat)/cm 3430, 3200, 1694; H NMR (250
MHz, CDCl ) δ 7.53 (br s, 1 H), 7.37-7.34 (m, 2 H), 7.29-7.23
3
(C
2
2
(m, 2 H), 5.61 (br s, 1 H), 4.76 (br s, 1 H), 2.00-1.85 (m, 3 H),
1.84-1.67 (m, 2 H), 1.41-1.30 (m, 1 H), 1.29-1.16 (m, 1 H),
+
(
3
1
2
3
3
3
+
13
1.04 (s, 3 H), 0.91 (s, 3 H), 0.51 (s, 3 H); C NMR (62.9 MHz,
H
26
N
2
O
O:
CDCl ) δ 185.4 (Cquat), 173.2 (Cquat), 135.9 (Cquat), 131.2 (Cquat),
3
+
(
M ) 334.20451, found 334.20384. Anal. Calcd for C22
C, 79.01; H, 7.84; N, 8.38. Found: C, 79.12; H, 7.85; N, 8.36.
2R )-2-Na p h t h a le n -1-yl-2-{[(1R ,4S )-1,7,7-t r im e t h yl-
bicyclo[2.2.1]h ep t-2-ylid en ]a m in o}eth a n a m id e (10a ) a n d
H
26
N
2
128.43 (2 CH), 128.40 (2 CH), 67.7 (CH), 54.2 (Cquat), 47.6
(Cquat), 43.7 (CH), 36.2 (CH ), 31.8 (CH ), 27.2 (CH ), 19.3
2
2
2
+
(
(CH
3 3 3
), 18.9 (CH ), 11.3 (CH ); MS m/z 318 (M ), 303, 277, 260,
239, 232, 218, 206, 192, 171, 169, 152, 140, 133, 125, 109, 95,
+
(
[
2S)-2-Naph th alen -1-yl-2-{[(1R,4S)-1,7,7-tr im eth ylbicyclo-
2.2.1]h ep t -2-ylid en ]a m in o}et h a n a m id e (10b). 1-Naph-
89, 83, 77, 69, 55, 43, 41; HRMS calcd for C18
H
23
N
2
OCl (M )
318.14987, found 318.15068. Anal. Calcd for C18
H
N OCl: C,
23 2
thylacetonitrile (251 mg, 1.50 mmol) was treated with 1
according to procedure B and the reaction mixture was
stirred for 2.5 h. Upon purification, (2R)-2-naphthalen-1-yl-
67.81; H, 7.27; N, 8.79. Found: C, 67.86; H, 7.19; N, 8.75.
(2R)-2-(4-Met h oxyp h en yl)-2-{[(1R,4S)-1,7,7-t r im et h -
ylbicyclo[2.2.1]h ep t-2-ylid en ]a m in o}eth a n a m id e (12a )
a n d (2S)-2-(4-Meth oxyp h en yl)-2-{[(1R,4S)-1,7,7-tr im eth -
ylbicyclo[2.2.1]h ep t -2-ylid en ]a m in o}et h a n a m id e (12b).
4-Methoxybenzyl cyanide (203 µL, 221 mg, 1.50 mmol) was
treated with 1 according to procedure B and the reaction mix-
ture was stirred for 7 h. Upon purification, (2R)-2-(4-meth-
oxyphenyl)-2-{[(1R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yli-
den]amino}ethanamide (12a ) and (2S)-2-(4-methoxyphenyl)-
2-{[(1R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yliden]amino}-
ethanamide (12b) were isolated by column chromatography
on silica gel as an oily mixture of inseparable diastereoisomers
in a 1:1 ratio (355 mg, 75%).
2
-{[(1R,4S)-1,7,7-trimethylbicyclo[2.2.1]hept-2-yliden]amino}-
ethanamide (10a , 154 mg, 31%) was first eluted followed by
2S)-2-naphthalen-1-yl-2-{[(1R,4S)-1,7,7-trimethylbicyclo[2.2.1]-
hept-2-yliden]amino}ethanamide (10b, 266 mg, 53%).
(
2
5
1
0a : colorless powder, mp 156-158 °C; [R]
3
D
-127° (c 1.04,
-
1
1
CHCl
MHz, CDCl
); IR νmax (neat)/cm 3420, 1696, 1653; H NMR (250
) δ 8.42 (d, J ) 8.4 Hz, 1 H), 7.83-7.72 (m, 2 H),
.63 (br s, 1 H), 7.56-7.36 (m, 4 H), 6.39 (br s, 1 H), 5.45 (s, 1
H), 2.46-2.37 (m, 1 H), 1.81 (t, J ) 4.4 Hz, 1 H), 1.73-1.62
m, 1 H), 1.55 (dt, J ) 11.5, 3.7 Hz, 1 H), 1.33 (d, J ) 17.3 Hz,
H), 1.20-1.08 (m, 1 H), 1.05 (s, 3 H), 0.89 (s, 3 H), 0.77 (s, 3
3
7
(
1
1
3
Mixture of 12a /12b: IR νmax (neat)/cm-1 3430, 3269, 1686,
H), 0.76-0.70 (m, 1 H); C NMR (62.9 MHz, CDCl
quat), 175.6 (Cquat), 136.5 (Cquat), 134.1 (Cquat), 131.6 (Cquat),
3
) δ 185.3
+
(C
1654; MS m/z 314 (M ), 271, 227, 214, 202, 175, 164, 148, 136,
1
1
28.7 (CH), 128.2 (CH), 126.4 (CH), 126.2 (CH), 125.7 (CH),
25.3 (CH), 125.0 (CH), 65.2 (CH), 54.6 (Cquat), 47.1 (Cquat), 43.9
121, 109, 93, 91, 81, 77, 69, 67, 55; HRMS calcd for C19
H
26
N
2
O
2
+
(M ) 314.19940, found 314.19907.
2
), 31.4 (CH
2 2 3 3
), 27.0 (CH ), 19.6 (CH ), 18.9 (CH ),
12a : 1H NMR (250 MHz, CDCl ) δ 7.51 (br s, 1 H), 7.34-
3
(CH), 36.1 (CH
+
1
1
3
7
1.4 (CH
27, 115, 95, 69, 55, 41; HRMS calcd for C22
34.20451, found 334.20483. Anal. Calcd for C22
3
); MS m/z 334 (M ), 290, 222, 185, 172, 155, 141,
7.30 (m, 2 H), 6.86-6.82 (m, 2 H), 6.09 (br s, 1 H), 4.71 (s, 1
H), 3.78 (s, 3 H), 2.45-2.35 (m, 1 H), 1.91 (t, J ) 4.3 Hz, 1 H),
1.80-1.63 (m, 2 H), 1.55 (d, J ) 17.2 Hz, 1 H), 1.25-1.15 (m,
+
H
26
N
2
O (M )
H
N O: C,
26 2
9.01; H, 7.84; N, 8.38. Found: C, 78.94; H, 7.89; N, 8.39.
1 H), 1.03 (s, 3 H), 0.98-0.93 (m, 1 H), 0.93 (s, 3 H), 0.75 (s, 3
2
5
13
1
0b: colorless powder, mp 190-191.5 °C; [R]
D
+133° (c
3
H); C NMR (100.6 MHz, CDCl ) δ 184.9 (Cquat), 175.9 (Cquat),
-
1
1
1
.01, CHCl
3
); IR νmax (neat)/cm 3429, 3196, 1697, 1651; H
) δ 8.42 (d, J ) 8.4 Hz, 1 H), 7.82-7.71
m, 3 H), 7.56-7.34 (m, 4 H), 6.26 (br s, 1 H), 5.46 (s, 1 H),
158.9 (Cquat), 131.8 (Cquat), 128.1 (2 CH), 113.9 (2 CH), 67.3
(CH), 55.4 (CH ), 54.2 (Cquat), 47.0 (Cquat), 43.9 (CH), 35.8 (CH ),
31.7 (CH ), 27.3 (CH ), 19.5 (CH ), 19.0 (CH ), 11.2 (CH ).
12b: 1H NMR (250 MHz, CDCl
) δ 7.52 (br s, 1 H), 7.34-
NMR (250 MHz, CDCl
(
3
3
2
2
2
3
3
3
1
.92-1.63 (m, 5 H), 1.40 (dt, J ) 12.5, 3.9 Hz, 1 H), 1.26-1.15
3
(
(
m, 1 H), 1.04 (s, 3 H), 0.83 (s, 3 H), 0.25 (s, 3 H); 13C NMR
7.29 (m, 2 H), 6.86-6.79 (m, 2 H), 6.65 (br s, 1 H), 4.71 (s, 1
H), 3.75 (s, 3 H), 2.00-1.95 (m, 1 H), 1.92-1.59 (m, 4 H), 1.38-
62.9 MHz, CDCl
3
) δ 186.1 (Cquat), 175.8 (Cquat), 136.4 (Cquat),
34.2 (Cquat), 131.8 (Cquat), 128.9 (CH), 128.4 (CH), 126.5 (CH),
26.2 (CH), 125.9 (CH), 125.5 (CH), 125.3 (CH), 65.9 (CH), 54.7
quat), 48.2 (Cquat), 44.1 (CH), 37.0 (CH ), 32.3 (CH ), 27.6
); MS m/z 335 (MH ),
1
3
1
1
1.14 (m, 2 H), 1.01 (s, 3 H), 0.89 (s, 3 H), 0.49 (s, 3 H);
NMR (100.6 MHz, CDCl
(Cquat), 131.4 (Cquat), 128.1 (2 CH), 113.7 (2 CH), 67.8 (CH),
55.2 (CH ), 54.7 (Cquat), 47.9 (Cquat), 43.7 (CH), 36.2 (CH ), 31.6
(CH ), 27.1 (CH ), 19.3 (CH ), 18.8 (CH ), 11.4 (CH ).
C
3
) δ 184.8 (Cquat), 176.0 (Cquat), 158.6
(C
2
2
+
(CH
2
), 19.4 (CH
3
), 19.3 (CH
3
), 11.8 (CH
3
3
2
+
3
9
34 (M ), 291, 262, 234, 222, 206, 185, 168, 156, 141, 129, 109,
5, 81, 69, 55, 41; HRMS calcd for C22
2
2
3
3
3
+
H
26
N
2
O (M ) 334.20451,
Tr im eth ylcyclopen t-3-en yl)eth an am ide (R-Cam ph olen -
found 334.20420. Anal. Calcd for C22
H
26
N
2
O: C, 79.01; H, 7.84;
31,32
ic Am id e) (13)
a n d 1,8,8-Tr im eth yl-2-a za bicyclo[3.2.1]-
N, 8.38. Found: C, 78.64; H, 7.80; N, 8.40.
2R)-2-(4-Ch lor op h en yl)-2-{[(1R,4S)-1,7,7-t r im et h yl-
bicyclo[2.2.1]h ep t-2-ylid en ]a m in o}eth a n a m id e (11a ) a n d
2S)-2-(4-Ch lor oph en yl)-2-{[(1R,4S)-1,7,7-tr im eth ylbicyclo-
31,33
octa n -3-on e (14).
Rea ction betw een 4-n itr op h en yla c-
(
eton itr ile a n d (+)-ca m p h or yloxa zir id in e 1: 4-Nitrophenyl-
acetonitrile (245 mg, 1.513 mmol) was treated with 1 according
to procedure B and the reaction mixture was stirred for 4 h at
(
7
794 J . Org. Chem., Vol. 67, No. 22, 2002